Literature DB >> 6127523

Streptomycin-resistant Haemophilus ducreyi.

V S Rajan, E H Sng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6127523     DOI： 10.1016/s0140-6736(82)90072-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Treatment of chancroid.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.

Authors:  M J Sanson-le Pors; I M Casin; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.

Authors:  S Hafiz; B M Jones; G R Kinghorn; B I Duerden
Journal:  Genitourin Med       Date:  1986-08

5.  Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethoprim, and erythromycin in the treatment of chancroid.

Authors:  B Kumar; V K Sharma; V Bakaya
Journal:  Genitourin Med       Date:  1990-04

Review 6.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.